Clinical Trial Update: Mesenchymal Stromal Cells for Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mesenchymal stromal cells for ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Sean Savitz | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: WITHDRAWN